Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Perimeter Medical Imaging Ai, Inc. Appoints Anantha Kancherla As VP, Advanced Driver Assistance Systems and Adrian Mendes As CEO

PRIVATEApr 16, 2024about 2 years ago

Position

Chief Executive Officer

Company

Perimeter Medical Imaging AI

Adrian Mendes
Dallasmedical devices

Description

Perimeter Medical Imaging AI, Inc. announced the appointment of Anantha Kancherla as Vice President of Advanced Driver Assistance Systems and Adrian Mendes as Chief Executive Officer.

Company Information

Company

Perimeter Medical Imaging AI

Location

8585 N Stemmons Fwy

Dallas, Texas, United States

About

Perimeter Medical Imaging AI is a pioneering medical technology company driven to transform cancer surgery with advanced imaging tools that address unmet medical needs. Our goal is to advance the standard of care, improve patient outcomes, and lower healthcare costs. With headquarters in Toronto, Canada and U.S. headquarters in Dallas, Texas, Perimeter's technology delivers ultra-high-resolution, real-time imaging to help physicians visualize microscopic tissue structures in the surgical margins. Simply put, we provide the medical community with the clarity needed to make critical decisions in the operating room. Available now across the U.S., Perimeter’s FDA-cleared S-Series OCT, powered by Optical Coherence Tomography, gives surgeons cross-sectional visualization of surgical margins and excised tissues at the cellular level in real time. Our next-generation technology, the Perimeter B-Series OCT, uses ImgAssist AI, a powerful artificial intelligence and machine learning tool designed to assist with visualizing margins. A multi-site, randomized clinical trial is underway to test the B-Series against the current standard of care and assess the impact on re-operation rates for patients undergoing breast conservation surgery.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Perimeter Medical Imaging AI's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.